Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on March 11, 2025

Teknova and Pluristyx Announce Collaboration to Streamline the Manufacture of Next-Generation Cell Therapies
HOLLISTER, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), and Pluristyx, Inc., today announced that the companies are collaborating to produce and commercialize Pluristyx's PluriFreeze™ product line, a …

RevMaxx Enhances Medical Scribe Capabilities with New Features
RevMaxx has introduced new AI-powered medical scribing features designed to streamline clinical documentation and reduce physician burnout. TAMPA, FL, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- Physician burnout is at an all-time high, with …

Celiveo 365 applies AI-DLP Data Loss Protection to Microsoft Universal Print Cloud print management
Celiveo 365 integrates seamlessly with Microsoft Universal Print, adding a suite of Enterprise features now including AI-based DLP protecting against data leak MERIDIAN, ID, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- Celiveo 365, a leader in …

Behavidence Launches New Consumer App to Transform Mental Wellness with Playful and Seamless Management
Behavidence launches a new version of their consumer app for mental wellness tracking, reducing stigma …

INDIGO Biosciences Launches Dopamine Receptor D1 Reporter Assay for Neurological and Psychiatric Research
New Cell-Based Assay Supports Drug Discovery for DRD1-Targeted Therapies STATE COLLEGE, PA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- INDIGO Biosciences, a premier provider of cell-based assay solutions, has introduced its Human Dopamine …

Executive Producers of SGTI Documentary Series Finalize Business Selection and Begin Outreach
LONDON, UNITED KINGDOM, March 11, 2025 /EINPresswire.com/ -- The highly anticipated Sustainable Global Trade Initiative (SGTI) Documentary Series has reached a key milestone as its executive producers finalize its carefully curated list of businesses …

Florida Mesothelioma Victims Center Strongly Recommends the Gori Law Firm to an Auto-Truck Mechanic with Recently Diagnosed Mesothelioma or Lung Cancer in Florida to Call the Gori Law Firm-Get Better Compensation
TAMPA , FL, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- The Florida Mesothelioma Victims Center strongly recommends the Gori Law Firm for an auto-truck mechanic anywhere in Florida who has just been diagnosed with mesothelioma or lung cancer to …

Understanding the Sleep Aid Supplement Market : Key Trends and Insights
WILMINGTON, DE, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- According to the report, the sleep aid supplement market was valued at $6.8 billion in 2023, and is estimated to reach $11.8 billion by 2034, growing at a CAGR of 5.1% from 2024 to 2034. …

SleepScore Labs’ Digital Sleep Program First to Demonstrate Positive Results in Randomized Controlled Trial
Study of over 600 participants showed gains in sleep quality, using hyper-personalized sleep journeys and reimbursement in Germany’s health insurance system CARLSBAD, CA, UNITED STATES, March 11, 2025 /EINPresswire.com/ -- SleepScore Labs today …

Dein Schlaf by SleepScore wurde als erstes wissenschaftlich in einer großen Studie bestätigt
Eine Studie mit über 600 Teilnehmern belegt verbesserten Schlaf und reduzierten Stress. DUBLIN, IRELAND, March 11, 2025 /EINPresswire.com/ -- Das digitale Schlafverbesserungsprogramm von SleepScore Labs hat seine Wirksamkeit in einer randomisierten …

Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures
VANCOUVER, British Columbia, March 11, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAD), a company focused on opportunities within and outside of the cannabis industry, announces that it has entered …

Malatya Apricot | The Nutritional and Environmental Impact of Conventional Dried Apricots – Diced Dried Apricots
Malatya Apricot | Conventional - Diced Dried Apricots Supplier and Exporter MALATYA, BATTALGAZI , TURKEY, March 11, 2025 /EINPresswire.com/ -- Dried apricots have long been a staple in diets across the world, known for their rich nutritional profile …

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades
AUDUBON, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced two commercial launches: COHERE™ ALIF Spacer: The first Porous PEEK™ interbody spacer for anterior lumbar …

Oculis Reports Q4 and Full Year 2024 Financial Results and Provides Company Update
Successful 2024 marked by significant clinical advancements across Oculis’ late-stage and highly differentiated clinical pipeline targeting retina (OCS-01 in diabetic macular edema), neuro-ophthalmic (Privosegtor, OCS-05, in acute optic neuritis) and …

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., March 11, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on March 6, 2025, the Compensation Committee granted inducement awards consisting of a non-qualified stock option to purchase 51,500 shares of …

Polyrizon Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2024
Raanana, Israel, March 11, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the "Company" or "Polyrizon"), a development stage biotech company specializing in the development of innovative intranasal hydrogels, today announced that it has filed its …

Optinose Announces Reporting Date for Fourth Quarter and Full Year 2024 Financial Results
YARDLEY, Pa., March 11, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced the Company will report financial results for the fourth …

Zevra Reports Full Year 2024 and Fourth Quarter Financial Results
FY 2024 net revenue of $23.6 million, driven by net revenue of $12.0 million during fourth quarter of 2024 Entered into asset purchase agreement for sale of PRV for $150 million Company to host conference call and webcast today, Mar. 11, 2025, at 4:30 p.m. …

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance
ROCKVILLE, MD, March 11, 2025 — MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, …

Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2024
Acquired ImmPACT Bio and strengthened clinical pipeline with the addition of IMPT-314, a next-generation dual-targeting CD19/CD20 CAR T-cell product candidate for the treatment of aggressive large B-cell lymphoma (LBCL) Presented positive initial data from …